A growing body of evidence indicated that CTGF plays a pathological role in lung diseases, and several lines of evidence suggest that CTGF is also a profibrotic mediator of pulmonary fibrotic diseases such as IPF [7, 38]. The gene discussed is CCN2; the disease is idiopathic pulmonary fibrosis.